Strategic Growth SI-BONE is a global leader in sacroiliac joint solutions with a growing international demand, presenting an opportunity to expand distribution partnerships, clinical education programs, and reimbursement support in regions outside the US.

Procedural Demand The iFuse Implant System has been used in over 150,000 procedures and is driving steady revenue growth as volumes rise, indicating a strong upsell path for expanded product offerings and complementary SI joint care devices.

Financial Momentum Q2 2026 results show revenue growth and narrowing losses driven by increased U.S. procedure volumes and international demand, suggesting capacity for additional sales initiatives and enterprise-wide cross-sell opportunities.

Tech and Security Adoption of cloud and integration tools (Bo[email protected] and related platforms) alongside cybersecurity awareness highlights potential for selling IT/implementation services, data analytics partnerships, and training programs for site adoption.

Market Positioning As a focused solution in an underserved orthopedic niche, SI-BONE presents opportunities to engage with hospitals and clinics seeking innovative, minimally invasive SI joint solutions, plus value-based care discussions around outcome improvements and cost per procedure.